Meckel's diverticulum,2 and there is an increased-incidence of Meckel's diverticulum in Crohn's 
Discussion
Stones in a Meckel's diverticulum are rare; only 33 cases have been reported, and, of these, 14 have been radio-opaque.4 Most of the stones have been single or poorly calcified, but when multiple they are flat and triangular with a central translucency.5 The presence of an airfluid level should lead one to suspect a Meckel's diverticulum. The stones are thought to arise from stagnation of intestinal contents in a narrow-necked diverticulum, and in this case they contained a central nidus of undigested muscle fibre, presumably ingested meat.
An association between Meckel's diverticulum and Crohn's disease has been suggested.3 The reported incidence varies from 6% to 18 5%, compared with a normal incidence of Meckel's diverticulum of 2%.
Heaton, K W, and Read, A E, British Medical_Journal, 1969, 3, 494. 2 Sharma, G, and Benson, C K, Canadian Journal of Surgery, 1970, 13, 54. 3 Ekman, C N, Gastroenterology, 1958, 34, 130. 4Kavlie, H, and Marchioro, T L, Gastroenterology, 1972 T L, Gastroenterology, , 62, 1238 In necropsy samples from patients with Huntington's chorea the concentration both of gamma-aminobutyric acid (GABA) and of the related dipeptide homocarnosine have been found to be reduced in the substantia nigra, putamen, globus pallidus, and caudate nucleus. It has also been found that the activity of glutamic acid decarboxylase (GAD), the enzyme concerned in the production of GABA, is appreciably reduced and on the basis of these findings Bird and his colleagues suggested that the use of agents which increase brain GABA concentration might benefit patients with Huntington's chorea.' We have therefore studied the effect of sodium valproate (Epilim), a drug which inhibits GABA transaminase, the enzyme responsible for the breakdown of GABA, administered to five patients with choreiform movements.
Patients, methods, and results
The patients included three with hereditary Huntington's disease and two patients without family history whose severe choreiform movements developed late in life. Sodium valproate was administered in dosage maxima of 600-1200 mg/day. The effectiveness of the drug was assessed with particular attention to involuntary movements and gait. In four out of the five cases clinical assessment was supplemented by examination of films taken before and after treatment with the drug. 
